M1 macrophage-derived exosomes containing miR-150 inhibit glioma progression by targeting MMP16

Pengfei Yan1, Jia Wang2, Hongya Liu3

  • 1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei 430022, China.

Cellular Signalling
|May 27, 2023
PubMed

Insights

M1 macrophage exosomes carrying miR-150 inhibit glioblastoma cell growth. This microRNA targets MMP16, offering a novel therapeutic strategy for glioma treatment.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • M1 macrophages show anti-tumor properties, but their exosome-mediated mechanisms against glioblastoma are unclear.
  • Glioblastoma multiforme is an aggressive brain tumor with limited treatment options.

Purpose of the Study:

  • To investigate the role of M1 macrophage-derived exosomes in inhibiting glioblastoma cell proliferation.
  • To elucidate the molecular mechanism underlying this inhibition.

Main Methods:

  • Isolation and characterization of exosomes from M1 macrophages.
  • Treatment of glioblastoma cells with M1 macrophage exosomes.
  • Quantification of microRNA (miR-150) levels and its target (MMP16) expression.
  • Assessment of glioblastoma cell proliferation.

Main Results:

  • M1 macrophage exosomes significantly inhibited glioblastoma cell proliferation.
  • Exosomes were enriched with miR-150, which was crucial for the anti-proliferative effect.
  • miR-150 directly targeted and downregulated Matrix Metallopeptidase 16 (MMP16) in glioblastoma cells.

Conclusions:

  • M1 macrophage-derived exosomes carrying miR-150 inhibit glioblastoma progression by downregulating MMP16.
  • This exosome-mediated pathway presents a promising avenue for novel glioma therapeutics.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K